Asano Reiko, Anderson Kelley M, Koirala Binu, Abshire Martha, Himmelfarb Cheryl Dennison, Davidson Patricia M
J Cardiovasc Nurs. 2022;37(4):341-349. doi: 10.1097/JCN.0000000000000835. Epub 2021 Aug 19.
Heart failure is a troublesome condition with high healthcare utilization and cost. Most individuals with heart failure experience multiple symptoms including breathlessness, pain, depression, and anxiety.
The aim of this study was to review the literature describing the use of the Edmonton Symptom Assessment Scale to assess the burden of symptoms and the impact of symptoms on heart failure outcomes including quality of life and functional outcomes.
The search engines PubMed, Scopus, CINAHL, and Web of Science were searched from January 2001 to March 2020. A review of literature was undertaken using key terms "heart failure," "CHF," "cardiac failure," "heart decompensation," "myocardial failure," "Edmonton Symptom Assessment Scale". Hand searching of articles was also undertaken.
The search resulted in 33 relevant articles, which were imported into Rayyan, a Web-based systematic review software program. We present synthesis of results of studies (1) using the Edmonton Symptom Assessment Scale as an assessment of symptom burden and (2) evaluating the impact of symptom burden on quality of life and functional status.
This review highlighted the Edmonton Symptom Assessment Scale as a predictive instrument to identify symptom burden, symptom clusters, and symptom changes for patients living with heart failure. The clinical use of the Edmonton Symptom Assessment Scale may identify treatment priorities, promote self-management, inform the treatment plan, and advance effective therapeutic adjustments. The symptom burden in heart failure is high, and improving the symptom experience is an important focus of future healthcare interventions. The Edmonton Symptom Assessment Scale has utility in heart failure management due to psychometric properties and ease of administration.
The Edmonton Symptom Assessment Scale may be useful in measuring patient-reported symptom burden in patients with heart failure in the clinical setting because it correlates well with other heart failure measures on quality of life and functional outcomes and provides useful information on symptom burden.
心力衰竭是一种棘手的病症，医疗资源利用率高且成本高昂。大多数心力衰竭患者会经历多种症状，包括呼吸急促、疼痛、抑郁和焦虑。
本研究的目的是回顾描述使用埃德蒙顿症状评估量表评估症状负担以及症状对心力衰竭结局（包括生活质量和功能结局）影响的文献。
检索了2001年1月至2020年3月期间的搜索引擎PubMed、Scopus、CINAHL和科学网。使用关键词“心力衰竭”“慢性心力衰竭”“心力衰竭”“心脏失代偿”“心肌衰竭”“埃德蒙顿症状评估量表”对文献进行综述。还对文章进行了手工检索。
检索得到33篇相关文章，将其导入基于网络的系统评价软件程序Rayyan。我们呈现了以下研究结果的综合：（1）使用埃德蒙顿症状评估量表评估症状负担；（2）评估症状负担对生活质量和功能状态的影响。
本综述强调了埃德蒙顿症状评估量表作为一种预测工具，可用于识别心力衰竭患者的症状负担、症状集群和症状变化。埃德蒙顿症状评估量表的临床应用可能有助于确定治疗重点、促进自我管理、为治疗计划提供信息并推动有效的治疗调整。心力衰竭患者的症状负担很高，改善症状体验是未来医疗干预的一个重要重点。由于其心理测量特性和易于使用，埃德蒙顿症状评估量表在心力衰竭管理中具有实用价值。
埃德蒙顿症状评估量表在临床环境中测量心力衰竭患者报告的症状负担可能有用，因为它与其他心力衰竭生活质量和功能结局测量指标相关性良好，并提供有关症状负担的有用信息。
